Effect of Interleukin-1 α and Interleukin-1 β on Erythroid Progenitor Cell Growth in Serum Free Cultures: An In Vitro Study Relevant to the Pathogenesis of the Anemia of Chronic Disease

References

• Means, R. T. and Krantz, S. B. (1992). Progress in understanding the pathogenesis of the anemia of chronic disease. Blood, 80, 1639–47.
   PubMed Web of Science ®Google Scholar
• Means, R. T. (1995). Pathogenesis of the anemia of chronic disease: a cytokine-mediated anemia. Stem Cells, 13, 32–7.
   PubMed Web of Science ®Google Scholar
• Maury, C. PJ., Anderson, L. C., Teppo, A. M., Partanen, S. and Juvonen, E. (1988). Mechanism of anaemia in rheumatoid arthritis: demonstration of raised interleukin-1β concentrations in anaemic patients and of interleukin 1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukemia (HEL) cells in vitro. Ann. Rheum. Dis., 47, 972–8.
   PubMed Web of Science ®Google Scholar
• Schooley, J. C., Kullgren, B. and Allison, A. C. (1987). Inhibition by interleukin-1 of the action of erythropoietin on erythroid precursors and its possible role in the pathogenesis of hypoplastic anaemias. Brit. J. Hematol., 67, 11–7.
   PubMed Web of Science ®Google Scholar
• Ratajczak, M. Z., Ratajczak, J., Kuczynski, W. I. and Skorski, T. (1994). In vitro study of anemia in chronic inflammatory conditions. Effect. of recombiant interleukin-1 beta on human erythropoiesis. Pol. Arch. Med. Wewn., 91, 97–104.
   PubMedGoogle Scholar
• Aoki, I., Homori, M., Nakahara, K., Higashi, K. and Ishikawa, K. (1995). Effects of rhIL-lα, rhIL-1β, and rhlL-1 receptor antagonist on erythroid progenitors (CFU-E and BFU-E) in human bone marrow. Exp. Hematol., 23, 217–25.
   PubMed Web of Science ®Google Scholar
• De Jong, M. O., Wagemaker, G. and Wognum, A. W. (1995). Separation of myeloid and erythroid progenitors based on expression of CD34 and c-kit. Blood, 86, 4076–81.
   PubMed Web of Science ®Google Scholar
• Ratajczak, M. Z., Kuczynski, W. I., Sokol, L. D., Moore, J., Pletcher, C. and Gewirtz, A. M. (1995). Expression, and physiologic significance, of Kit Ligand and Stem Cell Tyrosine Kinase-1 Receptor Ligand in normal human CD34+, C-Kit R + marrow cells. Blood, 86, 2161–7.
   PubMed Web of Science ®Google Scholar
• Ratajczak, M. Z., Luger, S. M., DeRiel, K., Abrahm, J., Calabretta and Gewirtz, A. M. (1992). Role of the KIT protooncogene in normal and malignant human hematopoiesis. Proc. Natl. Acad. Sci. USA, 89, 1710–4.
   PubMed Web of Science ®Google Scholar
• Ratajczak, M. Z., Ratajczak, J., Kregenow, D. A. and Gewirtz, A. M. (1994). Growth factor stimulation of cryopreserved CD34+ bone marrow cells intended for transplant: an in vitro study to determine optimal timing of exposure to early acting cytokines. Stem Cells, 12, 599–603.
   PubMed Web of Science ®Google Scholar
• Sims, J. E., Acres, R. B., Grubin, C. E., McMahan, C. J., Wignall, J. M., March, C. J. and Dowler, S. K. (1989). Cloning the interleukin 1 receptor from human T cells. Proc. Natl. Acad. Sci. USA, 86, 8946–50.
   PubMed Web of Science ®Google Scholar
• Ratajczak, M. Z., Mitjavilla, M. T., Ratajczak, J., Kuczynski, W. I., Kregenow, D. and Gewirtz, A. M. (1994). Human erythropoiesis in a serum free culture system: a reappraisal of the role of insulin. Blood, 84, Suppl 1, 281a.
   Google Scholar
• Johnson, C. S., Keckler, J. D., Topper, M. I., Braunschweiger, P. G. and Furmanski, Ph. (1989). In vivo hematopoietic effects of recombinant interleukin-lα in mice: stimulation of granulocytic, monocytic, megakaryocytic, and early erythroid progenitors, suppresion of late-stage erythropoiesis, and reversal of erythroid suppression with erythropoietin. Blood, 73, 678–83.
   PubMed Web of Science ®Google Scholar
• Dinarello, ChA. and Wolff, S. M. (1993). The role of interleukin-1 in disease. N. Engl. J. Med., 328, 106–13.
   PubMed Web of Science ®Google Scholar
• Platanias, L. C. and Vogelzang, N. J. (1990). Interleukin-1: biology, pathophysiology and clinical prospects. JAMA, 89, 621–9.
   PubMed Web of Science ®Google Scholar
• Berardi, A. C., Wang, A., Levine, J. D., Lopez, P. and Scadden, P. (1995). Functional isolation and characterization of human hematopoietic stem cells. Science, 267, 104–8.
   PubMed Web of Science ®Google Scholar
• Jacobsen, S. E. W., Ruscetti, F. W., Dubois, C. M., Wine J. and. Keller, J. R. (1992). Induction of colony-stimulating receptor expression on hematopoietic progenitor cells: proposed mechanism for growth factor synergism. Blood, 80, 678–87.
   PubMed Web of Science ®Google Scholar
• Sims, J. E., Gayle, M. A., Black, J. L., Alderson, M. R., Bird, T. A., Giri, J. G., Colotta, F., Re, F., Mantovani, A., Shanebeck, K., Grabstein, K. H. and Dower, S. K. (1993). Interleukin 1 signaling occurs exclusively via the type 1 receptor. Proc. Natl. Acad. Sci. USA, 90, 6155–9.
   PubMed Web of Science ®Google Scholar
• Muench, M. O., Firpo, M. T. and Moore, M. S. (1993). Bone marrow transplantation with interleukin-1 plus kit-ligand ex vivo expanded bone marrow accelerates hematopoietic reconstitution in mice without the loss of stem cell lineage and proliferative potential. Blood, 81, 3463–3473.
   PubMed Web of Science ®Google Scholar
• Brugger, W., Heimfeld, S., Berenson, R. J., Mertelsmann, R. and Kanz, L. (1995). Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med, 333, 283–287.
   PubMed Web of Science ®Google Scholar
• Kobayashi, M., Imamura, M., Gotohda, Y., Maeda, S., Iwasaki, H., Sakurada, K., Kasai, M., Hapel, A. J. and Miyazaki, T. (1991). Synergistic effects of interleukin-1β and interleukin-3 on the expansion of human hematopoietic progenitor cells in liquid culture. Blood, 78, 1947–53.
   PubMed Web of Science ®Google Scholar
• Zucali, J. S. (1993). Stem cell manipulation for better treatment outcome. Cancer Res. Ther. Cont, 3, 221–5.
   Web of Science ®Google Scholar
• Appelbaum, F. R., Buhles, W., Singer, J. and Peters, W. P. (1994). Phase I study of recombinant human intreleukin-lβ (rhIL-1β) in patients with bone marrow failure. Bone Marrow Transplant, 14, 583–8.
   PubMed Web of Science ®Google Scholar
• Veltri, S. and Smith, J. W. (1996). Interleukin 1 trials in cancer patients: A review of the toxicity, antitumor and hematopoietic effects. Stem Cells, 14, 164–76.
   PubMed Web of Science ®Google Scholar
• Yonemura, Y., Ku, H., Hirayam, F., Souza, L. M. and Ogawa, M. (1996). Interleukin 3 and interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells. Proc Natl Acad Sci USA, 93, 4040–4044.
   PubMed Web of Science ®Google Scholar
• Ruoslati, E. and Reed, J. C. (1994). Anchorage dependence, integrins, and apoptosis. Cell 77, 477–81.
   PubMed Web of Science ®Google Scholar
• Rodriguez, C., Lacasse, C. and Hoang, T. (1996). Interleukin 1-β suppresses apoptosis in CD34 positive bone marrow cells through activation of the type I Il-1 receptor. J of Cell Physiol, 166, 387–395.
   PubMed Web of Science ®Google Scholar
• Means, R. T. and Krantz, S. B. (1993). Inhibition of human erythroid colony-froming units by tumor necrosis factor requires beta interferon. J. Clin. Invest, 91, 416–9.
   PubMed Web of Science ®Google Scholar
• Means, R. T., Dessypris, E. N. and Krantz, S. B. (1992). Inhibition of human erythroid colony-forming units by interleukin-1 is mediated by gamma interferon. J. Cell. Physiol 150, 59–64.
   PubMed Web of Science ®Google Scholar
• Jovcic, G., Ivanovic, Z., Biljanovic-Paunovic, L., Bugars-ki, D., Stosic-Grujicic and Milenkovic, P. (1996). The effect of IL-1 receptor antagonist on the proliferation of hematopoietic progenitor cells in regenerating bone marrow. Leukemia, 10, 564–569.
   PubMed Web of Science ®Google Scholar
• Boyd, H. K. and Lappin, T. R. J. (1991). Erythropoietin deficiency in the anaemia of chronic disorders. Eur. J. Haematol, 46, 198–201.
   PubMed Web of Science ®Google Scholar